Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effects of AMT-162 Gene Therapy for Adults with SOD1 ALS

    Not recruiting

    1 1 1
    Investigated Diseases:
    Sweden
  • Study on the Effects of VHB937 in Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark Finland France Germany Ireland +5
  • Study on the Effects of Triumeq (Abacavir Sulfate, Lamivudine, Dolutegravir Sodium) in Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    Ireland The Netherlands Slovenia Spain Sweden
  • Study of Tofersen for Adults with Presymptomatic Amyotrophic Lateral Sclerosis (ALS) Due to SOD1 Gene Mutation

    Not recruiting

    3 1
    Investigated Drugs:
    France Germany Italy Poland Spain Sweden
  • Study on the Safety and Efficacy of ARGX-119 for Adults with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1
    Belgium Denmark France The Netherlands Sweden
  • Study of Lithium Treatment for Patients with Amyotrophic Lateral Sclerosis (ALS) to Evaluate Survival Rate

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium The Netherlands Spain Sweden
  • Study on the Effects of NX210c and Glucose in Adults with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1 1
    Investigated Diseases:
    France
  • Study of utreloxastat (PTC857) in adults with Amyotrophic Lateral Sclerosis (ALS) to evaluate its effectiveness in slowing disease progression

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Ireland Italy +5
  • Study on the Safety and Effects of AP-101 for Patients with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    2 1
    Sweden
  • Study on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium France Germany Ireland Italy The Netherlands +4